Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
3.190
+0.240 (8.14%)
At close: Oct 8, 2025, 4:00 PM EDT
3.190
0.00 (-0.01%)
After-hours: Oct 8, 2025, 7:34 PM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $119.73 million as of October 8, 2025. Its market cap has increased by 30.57% in one year.
Market Cap
119.73M
Enterprise Value
-42.27M
1-Year Change
30.57%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $119.73M, a decrease of -78.73%. That is a compound annual growth rate of -60.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 110.72M | -18.04% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.90B |
| Johnson & Johnson | 451.83B |
| AbbVie | 411.24B |
| UnitedHealth Group | 328.42B |
| AstraZeneca | 265.89B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.76B |